Pharma Likelihood Of Approval
We are the trusted, gold standard intelligence provider to the world’s largest industries
GlobalData powers faster, more informed decisions with:
- Granular industry intelligence: We develop deep, vertical-specific intelligence tailored to your industry, providing 360° insight.​
- Exhaustive coverage: We synthesize our vast data universe into formats that support your decision-making needs, covering the sectors, themes, companies and geographies that matter to you. ​
- Proprietary datasets: We provide you with access to untapped pools of intelligence generated from our proprietary datasets and primary research capabilities. ​
- Robust methodologies: The quality and timeliness of our data is a key differentiator. We leverage robust research methodologies to turn millions of data points into trusted intelligence.
Thousands of companies, government organizations, and decision makers rely on GlobalData
We have a track record of serving truly diverse clients, including:
- Corporates: From helping the C-suite refine strategy to powering innovation in marketing and R&D, our corporate use cases are endless. ​
- Investment firms: We help financial analysts develop robust long-term strategies and get alpha signals before the rest. ​
- Professional services: We give consultants, legal, and accounting firms the critical insights to make faster, more informed decisions. ​
- Other sectors: From media to academia, we work with sectors as diverse as our data. ​
The trusted, actionable and future-proof insight you need to stay ahead
We have decades of experience in being the gold standard intelligence provider based on: ​
- Unique data: Proprietary datasets built from terabytes of data. Our unmatched intelligence gives you true strategic advantage.
- Expert analysis: Leverage collective expertise. Count on our extensive team of researchers, analysts, subject matter experts, and journalists, plus thousands of external thought-leaders.​
- Real intelligence over AI: Experience a level of analysis that leaves AI in the dust. Unlock the proprietary datasets unseen by AI and gain a decisive edge. ​
- Time-saving research solutions: Save hundreds of hours on research. Our comprehensive reports let you focus on delivering actionable insights - not searching for them. ​
- Unparalleled global coverage: Tap into insights from anywhere. Our extensive global coverage offers an unrivalled view of the market landscape.​
- One platform: Access all our unique data, expert analysis, and innovative solutions on one platform. ​
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Deupirfenidone in Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deupirfenidone in Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Deupirfenidone in FibrosisDrug Details: Deupirfenidone (SD-560, LYT-100) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - PL-3994 in Diastolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PL-3994 in Diastolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PL-3994 in Diastolic Heart FailureDrug Details:PL-3994 is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Brincidofovir in Polyomavirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brincidofovir in Polyomavirus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brincidofovir in Polyomavirus Infections Drug Details: Brincidofovir (Tembexa) is an alkoxyalkyl ester...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Erdafitinib in Duodenal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erdafitinib in Duodenal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erdafitinib in Duodenal Cancer Drug Details: Erdafitinib (Balversa, Erfandel) is an alkyldiarylamine...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Erdafitinib in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erdafitinib in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erdafitinib in High-Grade Glioma Drug Details: Erdafitinib (Balversa, Erfandel) is an alkyldiarylamine...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tucidinostat in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tucidinostat in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tucidinostat in Hepatocellular Carcinoma Drug Details: Tucidinostat (Epidaza, Hiyasta) is a...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Tucidinostat in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tucidinostat in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tucidinostat in Diffuse Large B-Cell Lymphoma Drug Details: Tucidinostat...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - PDS-0101 in Penile Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-0101 in Penile Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PDS-0101 in Penile CancerDrug Details:PDS-0101 is under development for the treatment of HPV-induced...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - PDS-0101 in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PDS-0101 in Rectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PDS-0101 in Rectal CancerDrug Details:PDS-0101 is under development for the treatment of HPV-induced...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Devimistat in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Devimistat in Pancreatic Ductal AdenocarcinomaDrug Details:Devimistat (CPI-613) is under development for the...